Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

ARTRYA Ltd

Healthcare AU AYA

3.37AUD
0.35(11.59%)

Last update at 2026-03-10T05:10:00Z

Day Range

3.103.38
LowHigh

52 Week Range

0.565.24
LowHigh

Fundamentals

  • Previous Close 3.02
  • Market Cap538.86M
  • Volume626729
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-21.04400M
  • Revenue TTM0.03M
  • Revenue Per Share TTM-
  • Gross Profit TTM -17.66300M
  • Diluted EPS TTM-0.17

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -16.37700M -13.97300M -11.11800M -16.62000M -4.07977M
Minority interest - - - - -
Net income -16.40600M -14.00000M -11.13600M -17.15500M -4.07977M
Selling general administrative 0.67M 0.47M 10.88M 8.98M 4.06M
Selling and marketing expenses 0.05M 0.09M - 1.70M -
Gross profit -15.98900M -13.24600M - - -
Reconciled depreciation 1.19M 2.00M 0.55M 0.20M -
Ebit -16.61800M -14.35800M -11.44600M -16.61300M -4.02900M
Ebitda -16.21200M -13.95500M -11.89000M -16.41100M -
Depreciation and amortization 0.41M 0.40M - 0.20M -
Non operating income net other - - - - -
Operating income -16.61800M -14.40000M -11.46400M -16.61300M -4.05302M
Other operating expenses 16.65M 14.40M 0.02M 16.79M 0.07M
Interest expense 0.03M 0.03M 0.02M 0.00700M 0.02M
Tax provision 0.03M 0.03M 0.02M 0.54M 0.00000M
Interest income 0.27M 0.46M 0.35M 0.07M 0.00182M
Net interest income 0.24M 0.43M 0.35M 0.05M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.03M 0.03M 0.02M 0.54M -
Total revenue 0.03M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses 0.63M 1.15M - 16.79M -
Cost of revenue 16.02M 13.25M - - -
Total other income expense net 0.24M 0.43M 0.98M 0.11M -
Discontinued operations - - - - -
Net income from continuing ops -16.40600M -14.00000M -11.13600M -17.15500M -
Net income applicable to common shares -16.40600M -14.00000M -11.13600M -17.15500M -4.08000M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 23.68M 19.01M 33.09M 43.87M 52.22M
Intangible assets 5.09M - 7.17M 3.67M 0.52M
Earning assets - - - - -
Other current assets 0.42M 0.38M 0.15M - -
Total liab 2.39M 2.21M 2.53M 3.23M 1.17M
Total stockholder equity 21.29M 16.80M 30.56M 40.64M 51.05M
Deferred long term liab - - - - -
Other current liab 1.02M 1.05M 0.88M 1.39M 0.17M
Common stock 75.05M 56.45M 56.44M 56.40M 55.80M
Capital stock - - 56.44M 56.40M 55.80M
Retained earnings -64.27800M -47.87200M -33.87200M -22.73600M 3.25M
Other liab - - - 0.02M 0.00300M
Good will - - - - -
Other assets - - - - -
Cash 11.33M 7.28M 20.13M 15.29M 50.13M
Cash and equivalents - - - - -
Total current liabilities 2.07M 1.57M 1.59M 2.06M 1.16M
Current deferred revenue - - - - 0.17M
Net debt -10.70800M -6.33372M - -13.91700M -50.07900M
Short term debt 0.70M 0.33M 0.00000M 0.22M 0.04M
Short long term debt - - - - -
Short long term debt total 0.62M 0.95M - 1.37M 0.05M
Other stockholder equity - - 7.99M 6.98M 1.38M
Property plant equipment - - 2.21M 2.32M 0.14M
Total current assets 17.13M 11.54M 23.71M 37.87M 51.56M
Long term investments - - - - -
Net tangible assets - - 23.39M 36.97M 13.39M
Short term investments 0.15M 0.00028M 0.13M 20.27M -
Net receivables 5.38M 3.87M 3.07M 1.99M 1.43M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.36M 0.20M 0.24M 0.45M 0.95M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 10.52M 8.23M - 6.98M -8.00500M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 5.73M - - -
Deferred long term asset charges - - - - -
Non current assets total 6.54M 7.47M 9.38M 6.00M 0.66M
Capital lease obligations - - 1.21M 1.37M 0.05M
Long term debt total - - 0.94M 1.15M 0.00962M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments 0.00700M 2.71M 20.00M -20.27400M -20.27400M
Change to liabilities - - -0.40800M 0.52M 0.84M
Total cashflows from investing activities 0.00700M 2.71M 16.27M -26.58600M -1.85700M
Net borrowings - - -0.26500M -0.10700M -0.03100M
Total cash from financing activities 18.46M -0.29900M -0.24500M 38.53M 14.10M
Change to operating activities - - -0.17300M 0.20M 0.13M
Net income -16.40600M -14.00000M -11.13600M -17.15500M -4.08000M
Change in cash 4.20M -12.99800M 4.85M 2.30M 10.75M
Begin period cash flow 7.13M 20.13M 15.29M 12.98M -
End period cash flow 11.33M 7.13M 20.13M 15.29M 12.98M
Total cash from operating activities -14.27100M -15.40700M -11.18500M -9.65100M -1.48700M
Issuance of capital stock 20.07M 0.01M 0.02M 40.01M -
Depreciation 1.19M 2.00M 0.52M 0.20M 0.04M
Other cashflows from investing activities 0.27M 2.75M 2.22M 0.07M 0.20M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables -1.44700M 0.62M 0.43M 0.69M -1.03100M
Sale purchase of stock -1.28400M 0.01M 0.02M -2.25300M 14.13M
Other cashflows from financing activities -1.28400M -0.31100M 0.00000M 0.78M -0.87100M
Change to netincome - - -0.45000M 5.89M 2.61M
Capital expenditures 0.26M 0.05M 0.29M 6.38M 0.09M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.30500M 0.69M 0.54M 0.97M 0.49M
Stock based compensation 2.14M 0.23M - - -
Other non cash items 0.11M -4.32100M - - -
Free cash flow -14.53400M -15.40700M -15.73800M -6.38000M -

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AYA
ARTRYA Ltd		 0.35 11.59% 3.37 - - 18581.28 5.50 5001.13 0.33
PME
Pro Medicus Ltd		 8.19 6.23% 139.69 54.24 59.88 52.76 30.70 48.72 62.97
EIQ
Echoiq Ltd		 0.03 3.60% 0.72 - - 5118.78 26.19 4851.25 -8.2701
CGS
Cogstate Ltd		 0.12 5.45% 2.32 24.22 19.61 6.67 5.02 4.21 13.11
ONE
Oneview Healthcare Plc		 - -% 0.22 - - 15.17 31.32 9.22 -3.5247

Reports Covered

Stock Research & News

View All

Profile

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

ARTRYA Ltd

1257 Hay Street, West Perth, WA, Australia, 6005

Key Executives

Name Title Year Born
Mr. John Windsor Barrington A.M., F.A.C.I.D., M.B.A. Co-founder, CEO, MD & Director NA
Mr. John Konstantopoulos B.E. Co-Founder, Exec. Director of Product & Director NA
Mr. Mark Wainwright Chief Financial Officer NA
Dr. Julien Flack Chief Technology Officer NA
Prof. Girish Dwivedi M.D. Chief Scientific Officer NA
Ms. Janice Marcon Chief People & Culture Officer NA
Dr. Jacob Agris M.D., Ph.D. Chief Medical Officer NA
Mr. Riaz Kingston Head of Bus. Devel. NA
Dr. Jacque J. Sokolov B.A., M.D. Non-Exec. Director, Chair & Pres of Artrya USA Inc 1955
Mr. Ted Schwab Co-CEO of Artrya USA Inc NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.